Pfizer restricts sale of its drugs used in executions

With this all 25 companies that produce medicines used in executions have blocked their sale for that purpose

Image
Bloomberg
Last Updated : May 14 2016 | 9:15 PM IST
Pfizer, the US's biggest drugmaker, introduced a new policy designed to restrict sales of seven of its drugs that have been used in lethal injections at prisons across the US, saying it strongly objects to the use of its medicines for the purpose of capital punishment.

The decision means all 25 companies that produce medicines used in executions have blocked their sale for that purpose, according to Reprieve, an international human rights organiSation that opposes the death penalty.

"Pfizer's actions cement the pharmaceutical industry's opposition to the misuse of medicines," said Maya Foa, director of Reprieve, in a statement. "This will mean that all FDA-approved manufacturers of all execution drugs have spoken out against the misuse of medicines in lethal injections and taken steps to prevent it."

Pfizer's new distribution system will limit sales to specific wholesalers, distributors and direct purchasers, who must then pledge not to resell the drugs to correctional institutions for use in executions. Any government purchasing groups must certify that the medicines they buy are for their own use, for medically prescribed patient care, and won't be sold or shared with any others.

"Pfizer will consistently monitor the distribution of these seven products, act upon findings that reveal noncompliance, and modify policies when necessary to remain consistent with our stated position against the improper use of our products in lethal injections," the New York-based company said in a statement posted on its website.

The limited-distribution products are: pancuronium bromide, potassium chloride, propofol, midazolam, hydromorphone, rocuronium bromide and vecuronium bromide.

Lethal injection was the primary method of execution in the 31 states that allowed the death penalty as of July 2015, with more than 1,260 inmates dying from the practice since 1976, according to the Death Penalty Information Center.

Most lethal injections begin with an anaesthetic or a sedative, followed by pancuronium bromide, which paralyses the inmate, according to the nonprofit group. Potassium chloride is then given to stop the heart.

The number of inmates who have been put to death has declined in recent years as correctional facilities had difficulty getting the medicines used in lethal injections, activists raised concerns about the practice and stories emerged about undue suffering and bungled execution attempts. While there were three botched executions in 2014 alone, the US Supreme Court upheld the practice in a decision issued last year.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 14 2016 | 9:07 PM IST

Next Story